Advanced search
Publication Cover
Journal of Obstetrics and Gynaecology Volume 42, 2022 - Issue 7
Submit an article Journal homepage
96
Views
0
CrossRef citations to date
0
Altmetric
Research Aricles

Family-based analysis of -675 4G/5G polymorphism in the PAI-1 gene of polycystic ovary syndrome in Chinese population

Xiaocui SongDepartment of Reproductive Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-7145-2336View further author information
ORCID Icon,
Li GeDepartment of Reproductive Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People’s Republic of ChinaView further author information
,
Dongsha WangDepartment of Reproductive Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People’s Republic of ChinaView further author information
,
Li LiDepartment of Reproductive Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People’s Republic of ChinaView further author information
,
Dongmei MaDepartment of Reproductive Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People’s Republic of ChinaView further author information
,
Xiu LiDepartment of Reproductive Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People’s Republic of ChinaView further author information
&
Xiaocui SongDepartment of Reproductive Medicine, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 3304-3308 | Published online: 05 Sep 2022

References

  • Azziz R, Carmina E, Chen Z, Dunaif A, Laven JSE, Legro RS, et al. 2016. Polycystic ovary syndrome. Nature Reviews. Disease Primers 2:16057.
  • Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265.
  • Barry JA, Azizia MM, Hardiman PJ. 2014. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update 20:748–758.
  • Escobar-Morreale HF. 2018. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews. Endocrinology 14:270–284.
  • Iftikhar S, Collazo-Clavell ML, Roger VL, St Sauver J, Brown RD, Cha S, Jr, et al. 2012. Risk of cardiovascular events in patients with polycystic ovary syndrome. Netherlands Journal of Medicine 70:74–80.
  • Kakoly NS, Khomami MB, Joham AE, Cooray SD, Misso ML, Norman RJ, et al. 2018. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Human Reproduction Update 24:455–467.
  • Lee YH, Song GG. 2014. Plasminogen activator inhibitor type-1 4G/5G and the MTHER 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology 175:8–14.
  • Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, et al. 2013. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Human Reproduction 28:2562–2569.
  • Liu Y, Sun M-G, Jiang R, Ding R, Che Z, Chen Y-Y, et al. 2014. Plasminogen activator inhibitor-1-675 4G/5G polymorphism and polycystic ovarian syndrome risk: a meta- analysis. Journal of Assisted Reproduction and Genetics 31:363–370.
  • Ma L-J, Mao S-L, Taylor KL, Kanjanabuch T, Guan YF, Zhang YH, et al. 2004. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor. Diabetes 53:336–346.
  • Merhi Z, Kandaraki EA, Diamanti-Kandarakis E. 2019. Implications and future perspectives of AGEs in PCOS pathophysiology. Trends in Endocrinology and Metabolism 30:150–162.
  • Michalska M, Iwan-Zietek I, Gnilka W, Dąbrowiecki S, Góralczyk B, Góralczyk K, et al. 2013. PAI-1 and α2-AP in patients with morbid obesity. Advances in Clinical and Experimental Medicine 22:801–807.
  • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. 2004. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertility and Sterility 81:19–25.
  • Sales MF, Sóter MO, Candido AL, Fernandes AP, Oliveira FR, Ferreira ACS, et al. 2013. Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/pro-inflammatory factors in polycystic ovary syndrome. Gynecological Endocrinology 29:936–939.
  • Shan Y, Wang A, Sun Y, Jiang W, Pang B, An Z, et al. 2013. Coagulation and fibrinolytic indices during the first trimester of pregnancy in women with polycystic ovary syndrome: a preliminary study. Reproductive Sciences 20:1390–1397.
  • Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, et al. 2007. Analysis of clinical characteristics in large-scale Chinese patient with polycystic ovary syndrome. Neuroendocrinology Letters 28:807–810.
  • Sun L, Lv H, Wei W, Zhang D, Guan Y. 2010. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G gene polymorphism are associated with increased risk of spontaneous abortions in polycystic ovary syndrome. Journal of Endocrinological Investigation 33:77–82.
  • Wang LH, Wang LM, Zhou N. 2015. 4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syndrome in Chinese patients: a meta-analysis. Archives of Gynecology and Obstetrics 292:683–686.
  • Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, et al. 2010. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. Journal of Clinical Endocrinology and Metabolism 95:2038–2049.
  • Zhang TT, Yuan L, Yang Y-M, Ren Y. 2015. The -675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS. European Review for Medical and Pharmacological Sciences 18:2326–2331.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.